Skip to main content

Table 4 Association of country-specific innovation activities with DALYs in the corresponding countries

From: Disease burden metrics and the innovations of leading pharmaceutical companies: a global and regional comparative study

Country Correlation coefficient (r)
(European Region)
 Germany 0.649**
 Hungary 0.670**
 United Kingdom 0.563*
(Western Pacific Region)
 China 0.660**
 Japan 0.659**
 South Korea 0.633**
(Region of the Americas)
 Canada 0.641**
 Uruguay 0.603*
 United States 0.647**
(South-East Asia Region)
 Bangladesh 0.169
 Indonesia 0.316
 Myanmar 0.084
(Eastern Mediterranean Region)
 Iran n/a
 Kuwait 0.430
 Saudi Arabia 0.346
(African Region)
 Rwanda n/a
 South Africa 0.311
 Uganda 0.394
  1. *p < 0.05
  2. **p < 0.01